Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Starling Medical

Request full access

An AI powered at home urine diagnostic remote patient monitoring platform

Houston, United StatesFounded 2019Health Tech & Medtech

About Starling Medical

Starling Medical operates in the healthcare technology sector, focusing on innovative solutions for neurogenic bladder dysfunction. The company serves patients with neurogenic bladder issues, a condition where nerve damage impairs the ability to sense bladder fullness and urinate on command. This condition affects over 3 million people in the United States alone. The current standard treatment involves the lifelong use of intermittent urinary catheters, which carry significant risks such as urosepsis, renal failure, and even death. Starling Medical aims to address these challenges with its AI and technology-enabled platform, the UrinControl System.

The UrinControl System offers a modern alternative to traditional urinary catheters, leveraging artificial intelligence to provide better bladder management. This system aims to reduce the high hospitalization rates and improve the quality of life for patients. The business model revolves around selling this advanced medical device and associated services to healthcare providers and directly to patients. Revenue is generated through the sale of the UrinControl System and possibly through subscription-based services for ongoing support and updates.

Starling Medical operates in a niche but critical market, targeting a specific patient demographic that faces severe health risks without proper bladder management. By offering a technologically advanced solution, the company positions itself as a leader in this specialized healthcare segment.

Source: Dealroom company data

Starling Medical in the Houston ecosystem

Live from Dealroom

The Starling Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A1 investor entered at this stage

  • Tech.Bio
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Starling Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Starling Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.